Cargando…
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607365/ https://www.ncbi.nlm.nih.gov/pubmed/33144565 http://dx.doi.org/10.1038/s41392-020-00374-6 |
_version_ | 1783604636744155136 |
---|---|
author | Abd El-Aziz, Tarek Mohamed Al-Sabi, Ahmed Stockand, James D. |
author_facet | Abd El-Aziz, Tarek Mohamed Al-Sabi, Ahmed Stockand, James D. |
author_sort | Abd El-Aziz, Tarek Mohamed |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7607365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76073652020-11-03 Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 Abd El-Aziz, Tarek Mohamed Al-Sabi, Ahmed Stockand, James D. Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-11-03 /pmc/articles/PMC7607365/ /pubmed/33144565 http://dx.doi.org/10.1038/s41392-020-00374-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Highlight Abd El-Aziz, Tarek Mohamed Al-Sabi, Ahmed Stockand, James D. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title | Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title_full | Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title_fullStr | Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title_full_unstemmed | Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title_short | Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 |
title_sort | human recombinant soluble ace2 (hrsace2) shows promise for treating severe covid19 |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607365/ https://www.ncbi.nlm.nih.gov/pubmed/33144565 http://dx.doi.org/10.1038/s41392-020-00374-6 |
work_keys_str_mv | AT abdelaziztarekmohamed humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19 AT alsabiahmed humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19 AT stockandjamesd humanrecombinantsolubleace2hrsace2showspromisefortreatingseverecovid19 |